Ramesh Narayanan, PhD, professor in the Department of Medicine and the Division of Hematology and Oncology at the University of Tennessee Health Science Center, has received a $455,000 grant from the National Cancer Institute for a two-year study of the underlying cause of the development of aggressive prostate cancer in African American men. Approximately 174,000… Read More
Despite a plethora of treatment options, the burdens of cardiovascular and kidney disease still pose significant challenges to public health and the economy. Efforts to reduce cardiovascular and kidney disease include scientific investigations into the mechanisms that underlie alterations in the function of blood vessels. These efforts include the research done in the laboratory of… Read More
A new research project that could impact and expand the discovery of new treatment options for sickle cell patients has received significant federal funding. The National Heart, Lung, and Blood Institute awarded nearly $1 million to Athena Starlard-Davenport, PhD, assistant professor of Genetics, Genomics, and Informatics in the UTHSC College of Medicine, for her project… Read More
The University of Tennessee Health Science Center Tuesday hosted its second online coronavirus symposium to an audience of more than 580. UTHSC’s first Coronavirus Online Symposium for providers and the public was held April 6, and highlighted the characteristics of the virus; its patterns of spread; and efforts led by the university and its partners to… Read More
The University of Tennessee Health Science Center will host its second Online Coronavirus Symposium July 28 from 11 a.m. to 1 p.m. CDT. Coronavirus Symposium – July Update is free and open to health care practitioners and the public via Zoom. The event is part of the university’s ongoing efforts to share essential coronavirus information… Read More
Alex Dopico, MD, PhD, professor and Van Vleet Chair of Excellence in the Department of Pharmacology, Addiction Science, and Toxicology, and Anna Bukiya, PhD, associate professor in the Department of Pharmacology, Addiction Science, and Toxicology, have been awarded $2.4 million from the National Heart, Lung, and Blood Institute (NHLBI) to explore how cholesterol interacts with… Read More
Patients with end stage renal disease (ESRD) face an increased risk of death due in part to cardiovascular problems caused by chronic inflammation. Efforts to reduce this inflammation have tended to target dialysis-related procedures and the accumulation of toxic waste products. These efforts have been largely unsuccessful, and researchers, such as Keiichi Sumida, MD, MPH,… Read More
“We are all going to have to get comfortable with being uncomfortable,” said Altha Stewart, MD, as she moderated a community conversation Wednesday hosted by the UTHSC College of Medicine titled, “Why Aren’t We All Mad? A Dialogue on Structural Racism in the Health Care System.” More than 400 joined Zoom for the dialogue, the… Read More
